DURECT Corporation (DRRX)
USD 0.79
(0.92%)
USD 0.79
(0.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.21 Million USD | 5.02% |
| 2022 | 2.11 Million USD | 12.99% |
| 2021 | 1.87 Million USD | 0.32% |
| 2020 | 1.86 Million USD | -44.9% |
| 2019 | 3.38 Million USD | -1.11% |
| 2018 | 3.42 Million USD | 8.16% |
| 2017 | 3.16 Million USD | -16.37% |
| 2016 | 3.78 Million USD | -3.45% |
| 2015 | 3.91 Million USD | 7.55% |
| 2014 | 3.64 Million USD | 4.0% |
| 2013 | 3.5 Million USD | 3.03% |
| 2012 | 3.39 Million USD | 4.52% |
| 2011 | 3.25 Million USD | 14.67% |
| 2010 | 2.83 Million USD | 1.32% |
| 2009 | 2.79 Million USD | -19.45% |
| 2008 | 3.47 Million USD | 77.02% |
| 2007 | 1.96 Million USD | -4.34% |
| 2006 | 2.05 Million USD | 0.24% |
| 2005 | 2.04 Million USD | 6.12% |
| 2004 | 1.92 Million USD | 1.42% |
| 2003 | 1.9 Million USD | 11.42% |
| 2002 | 1.7 Million USD | -8.42% |
| 2001 | 1.86 Million USD | -30.5% |
| 2000 | 2.68 Million USD | 1326.6% |
| 1999 | 188 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.47 Million USD | 3.17% |
| 2024 Q1 | 2.39 Million USD | 8.07% |
| 2023 Q2 | 2.26 Million USD | 2.31% |
| 2023 Q1 | 2.21 Million USD | 4.64% |
| 2023 Q4 | 2.21 Million USD | -11.98% |
| 2023 FY | 2.21 Million USD | 5.02% |
| 2023 Q3 | 2.52 Million USD | 11.45% |
| 2022 FY | 2.11 Million USD | 12.99% |
| 2022 Q1 | 2.07 Million USD | 11.02% |
| 2022 Q3 | 2.26 Million USD | 6.38% |
| 2022 Q2 | 2.13 Million USD | 2.75% |
| 2022 Q4 | 2.11 Million USD | -6.88% |
| 2021 Q1 | 1.95 Million USD | 4.88% |
| 2021 FY | 1.87 Million USD | 0.32% |
| 2021 Q4 | 1.87 Million USD | -17.62% |
| 2021 Q2 | 1.91 Million USD | -1.89% |
| 2021 Q3 | 2.27 Million USD | 18.35% |
| 2020 Q3 | 3.62 Million USD | 4.86% |
| 2020 Q1 | 3.31 Million USD | -2.16% |
| 2020 FY | 1.86 Million USD | -44.9% |
| 2020 Q4 | 1.86 Million USD | -48.62% |
| 2020 Q2 | 3.46 Million USD | 4.53% |
| 2019 Q4 | 3.38 Million USD | -6.5% |
| 2019 Q2 | 3.66 Million USD | 7.48% |
| 2019 Q1 | 3.41 Million USD | -0.32% |
| 2019 Q3 | 3.61 Million USD | -1.28% |
| 2019 FY | 3.38 Million USD | -1.11% |
| 2018 Q3 | 3.48 Million USD | 6.8% |
| 2018 FY | 3.42 Million USD | 8.16% |
| 2018 Q1 | 3.25 Million USD | 2.88% |
| 2018 Q2 | 3.26 Million USD | 0.28% |
| 2018 Q4 | 3.42 Million USD | -1.84% |
| 2017 Q2 | 3.71 Million USD | 7.28% |
| 2017 Q1 | 3.46 Million USD | -8.46% |
| 2017 FY | 3.16 Million USD | -16.37% |
| 2017 Q3 | 3.15 Million USD | -15.05% |
| 2017 Q4 | 3.16 Million USD | 0.25% |
| 2016 Q3 | 3.64 Million USD | -12.41% |
| 2016 Q1 | 4 Million USD | 2.3% |
| 2016 Q2 | 4.15 Million USD | 3.74% |
| 2016 Q4 | 3.78 Million USD | 3.87% |
| 2016 FY | 3.78 Million USD | -3.45% |
| 2015 Q3 | 3.97 Million USD | 1.09% |
| 2015 Q4 | 3.91 Million USD | -1.38% |
| 2015 FY | 3.91 Million USD | 7.55% |
| 2015 Q1 | 3.8 Million USD | 4.5% |
| 2015 Q2 | 3.92 Million USD | 3.23% |
| 2014 Q1 | 3.51 Million USD | 0.23% |
| 2014 Q2 | 4.55 Million USD | 29.74% |
| 2014 FY | 3.64 Million USD | 4.0% |
| 2014 Q3 | 3.81 Million USD | -16.25% |
| 2014 Q4 | 3.64 Million USD | -4.51% |
| 2013 FY | 3.5 Million USD | 3.03% |
| 2013 Q4 | 3.5 Million USD | 11.0% |
| 2013 Q3 | 3.15 Million USD | 0.13% |
| 2013 Q1 | 3.05 Million USD | -10.03% |
| 2013 Q2 | 3.15 Million USD | 3.04% |
| 2012 Q1 | 3.23 Million USD | -0.58% |
| 2012 Q2 | 3.17 Million USD | -1.73% |
| 2012 FY | 3.39 Million USD | 4.52% |
| 2012 Q4 | 3.39 Million USD | 3.28% |
| 2012 Q3 | 3.29 Million USD | 3.59% |
| 2011 Q3 | 3.13 Million USD | -4.01% |
| 2011 FY | 3.25 Million USD | 14.67% |
| 2011 Q4 | 3.25 Million USD | 3.77% |
| 2011 Q2 | 3.26 Million USD | 10.45% |
| 2011 Q1 | 2.95 Million USD | 4.23% |
| 2010 Q3 | 2.96 Million USD | 3.93% |
| 2010 FY | 2.83 Million USD | 1.32% |
| 2010 Q2 | 2.85 Million USD | 7.58% |
| 2010 Q4 | 2.83 Million USD | -4.32% |
| 2010 Q1 | 2.65 Million USD | -5.29% |
| 2009 Q4 | 2.79 Million USD | -2.88% |
| 2009 FY | 2.79 Million USD | -19.45% |
| 2009 Q1 | 2.63 Million USD | -24.04% |
| 2009 Q2 | 2.73 Million USD | 3.71% |
| 2009 Q3 | 2.88 Million USD | 5.3% |
| 2008 Q1 | 2.43 Million USD | 24.15% |
| 2008 Q3 | 2.83 Million USD | 6.67% |
| 2008 Q2 | 2.65 Million USD | 8.86% |
| 2008 FY | 3.47 Million USD | 77.02% |
| 2008 Q4 | 3.47 Million USD | 22.76% |
| 2007 Q2 | 2.03 Million USD | -0.15% |
| 2007 FY | 1.96 Million USD | -4.34% |
| 2007 Q4 | 1.96 Million USD | -3.16% |
| 2007 Q1 | 2.04 Million USD | -0.49% |
| 2007 Q3 | 2.02 Million USD | -0.59% |
| 2006 Q4 | 2.05 Million USD | -6.94% |
| 2006 Q3 | 2.2 Million USD | 4.8% |
| 2006 Q2 | 2.1 Million USD | 5.31% |
| 2006 Q1 | 1.99 Million USD | -2.39% |
| 2006 FY | 2.05 Million USD | 0.24% |
| 2005 Q2 | 1.91 Million USD | 0.26% |
| 2005 Q3 | 2.12 Million USD | 11.15% |
| 2005 Q4 | 2.04 Million USD | -3.63% |
| 2005 FY | 2.04 Million USD | 6.12% |
| 2005 Q1 | 1.9 Million USD | -1.19% |
| 2004 Q3 | 1.84 Million USD | -3.81% |
| 2004 Q4 | 1.92 Million USD | 4.78% |
| 2004 FY | 1.92 Million USD | 1.42% |
| 2004 Q1 | 2.05 Million USD | 8.1% |
| 2004 Q2 | 1.91 Million USD | -6.91% |
| 2003 Q1 | 1.66 Million USD | -2.23% |
| 2003 FY | 1.9 Million USD | 11.42% |
| 2003 Q2 | 1.69 Million USD | 1.74% |
| 2003 Q3 | 1.74 Million USD | 2.53% |
| 2003 Q4 | 1.9 Million USD | 9.25% |
| 2002 Q3 | 1.58 Million USD | 2.06% |
| 2002 Q4 | 1.7 Million USD | 7.83% |
| 2002 Q1 | 1.67 Million USD | -10.09% |
| 2002 Q2 | 1.55 Million USD | -7.46% |
| 2002 FY | 1.7 Million USD | -8.42% |
| 2001 FY | 1.86 Million USD | -30.5% |
| 2001 Q4 | 1.86 Million USD | -9.16% |
| 2001 Q3 | 2.05 Million USD | -14.11% |
| 2001 Q2 | 2.38 Million USD | 0.34% |
| 2001 Q1 | 2.38 Million USD | -11.22% |
| 2000 FY | 2.68 Million USD | 1326.6% |
| 2000 Q3 | 3.09 Million USD | -12.39% |
| 2000 Q4 | 2.68 Million USD | -13.37% |
| 2000 Q2 | 3.53 Million USD | 0.0% |
| 1999 FY | 188 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | 53.665% |
| Safety Shot Inc | 1.86 Million USD | -18.686% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 98.541% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 98.004% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 67.218% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 93.137% |
| Dynavax Technologies Corporation | 53.29 Million USD | 95.836% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 96.619% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 80.948% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 97.874% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 61.306% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 61.306% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -174.033% |
| Journey Medical Corporation | 10.2 Million USD | 78.258% |
| Alpha Teknova, Inc. | 11.59 Million USD | 80.861% |
| Procaps Group, S.A. | 96.83 Million USD | 97.708% |
| Theratechnologies Inc. | 6.06 Million USD | 63.419% |
| Harrow Health, Inc. | 10.86 Million USD | 79.58% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 18.389% |
| Biofrontera Inc. | 10.9 Million USD | 79.657% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 97.133% |
| Cronos Group Inc. | 30.33 Million USD | 92.686% |
| OptiNose, Inc. | 8.05 Million USD | 72.442% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -221899900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 61.064% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 92.146% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 17.112% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 51.859% |
| Radius Health, Inc. | 278.64 Million USD | 99.204% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 33.628% |
| ProPhase Labs, Inc. | 3.84 Million USD | 42.229% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.166% |
| Procaps Group S.A. | 96.83 Million USD | 97.708% |
| Alvotech | 74.43 Million USD | 97.019% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.936% |
| Rockwell Medical, Inc. | 5.87 Million USD | 62.204% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 82.435% |
| SIGA Technologies, Inc. | 64.21 Million USD | 96.545% |
| Tilray Brands, Inc. | 252.08 Million USD | 99.12% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 94.45% |
| Shineco, Inc. | 1.58 Million USD | -39.689% |
| PetIQ, Inc. | 159.3 Million USD | 98.607% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 1552.434% |
| Incannex Healthcare Limited | -10.01 Million USD | 122.157% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 94.206% |
| Alimera Sciences, Inc. | 1.87 Million USD | -18.095% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 94.112% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -37.793% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 50.502% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -772.413% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 78.622% |
| Hempacco Co., Inc. | 2.54 Million USD | 12.728% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 97.019% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 95.357% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 96.534% |
| Currenc Group, Inc. | 732.91 Thousand USD | -202.765% |
| Kamada Ltd. | 87.74 Million USD | 97.471% |
| Indivior PLC | 141.79 Million USD | 98.435% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -360.526% |
| Flora Growth Corp. | 8.5 Million USD | 73.919% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -772.413% |
| Evolus, Inc. | 10.99 Million USD | 79.824% |
| HUTCHMED (China) Limited | 50.25 Million USD | 95.585% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 97.903% |
| Akanda Corp. | 1.28 Million USD | -72.431% |